TOP STORIES
We all should probably start paying attention to Donald Trump. The leading candidate for the GOP presidential nomination put some details around his bluster when it comes to healthcare. His plan includes a repeal Obamacare and also allows prescription drugs to be imported. Like so many inconsistencies about The Donald, some of his ideas reflect proposals by Hillary Clinton and Bernie Sanders. – Reuters, STAT
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Looking for more HIMSS coverage? We have a separate HIMSS16 wrapup plus a dedicated daily newsletter with more news all this week.
LIFE SCIENCES
A new startup is developing a “PARP” inhibitor cancer drug. Ribon Therapeutics has rolled out of MIT is lead by three venture funds, including Osage and U.S. Venture Partners. – Xconomy
Johnson & Johnson launched a new JLABS life science incubator in Houston to hold up to 50 startups. – MassDevice
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Another day another change at Valeant: Deb Jorn has resigned in her role as executive vice president, running the U.S. Dermatology and Gastrointestinal businesses. Executives within the company are moving in to fill her spot. – PR Newswire
Roche has sent its HbA1c testing solution for diabetes to the FDA. – PR Newswire
The approved a new indication expanding the use of AstraZeneca’s breast cancer drug FASLODEX. – Business Wire
Cesca Therapeutics announced a 1-for-20 reverse stock split to keep the company on the Nasdaq. – Sacramento Business Journal
PAYERS-PROVIDERS
Independence Blue Cross and Thomas Jefferson University officially launched their joint Entrepreneurs-in-Residence program, funding to startups to the tune of $150,000 each. – Philadelphia Business Journal
New York’s attorney general is investigating state health-insurance companies for rationing care related to hepatitis C drugs. – Wall Street Journal
TECHNOLOGY
Drive Capital, which does a notable amount of health IT investing, has raised $202 million toward a $250 million fund. – PE Hub
Crunching data to battle Zika: Google is working with UNICEF to analyze data to anticipate the spread of the Zika virus. – Reuters
What’s driving McKesson’s $3 billion buying spree? – San Francisco Business Times
Here’s a chicken-or-the-egg statement from Accenture as it shows increasing adoption of digital health tools: “Healthcare providers will need to weave digital capabilities into the core of their business model so that it becomes embedded in everything they do.” – Business Wire
POLITICS
He goes out with a whimper. Ben Carson is out of the presidential campaign. – CNN
A LITTLE BIT EXTRA
One of the clicked – and disturbing – big-data analyses of the year. A leading porn site has broken down most popular searches by country and American states. We all have issues. – Vocativ
Photo: Getty Images
